Form 8-K Evolent Health, Inc. For: Feb 22
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 9/22/2026
- Nasdaq notches record-high close, AI optimism reignites and Treasury yields retreat
- Meta AI agent ‘Muse’ triggers massive tech rally as chips and Wall Street soar
- Oil price dips to $100 on hopes of US-Iran diplomacy, partial recovery in Saudi exports
- Paramount, Warner Bros jump on report of settlement progress in merger fight
- Investors may be underpricing how far rate hikes could go, Deutsche says
- Pennsylvania measles cases near 800 as outbreak grows
- A timeline of Trump administration moves to weaken endangered species protections
- Meta AI agent ‘Muse’ triggers massive tech rally as chips and Wall Street soar
- Nasdaq notches record-high close, AI optimism reignites and Treasury yields retreat
- SpaceX and Tesla’s AI linkup is getting deeper. Here’s what Morgan Stanley sees
Evolent Health (EVH) PT Raised to $63 at Cowen
February 23, 2023 1:04 PM ESTCowen analyst Charles Rhyee raised the price target on Evolent Health (NYSE: EVH) to $63.00 (from $59.00) while maintaining a Outperform rating following results.
The analyst commented, "EVH reported adj. EBITDA and revenue above cons. and introduced 2023 guide (adj. EBITDA of $180M-$200M) that was... More
